Related Experiment Videos
Meningitis. Update of recommendations for the neonate
Insights
Bacterial meningitis cases caused by Hemophilus influenzae type B are increasing in infants. Chloramphenicol is recommended for initial treatment in infants over one month old to improve outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Bacterial meningitis poses a significant threat to infants.
- Increasing isolation rates of Hemophilus influenzae type B (Hib) have been observed.
Purpose of the Study:
- To analyze trends in Hemophilus influenzae type B meningitis in children.
- To recommend optimal treatment strategies for bacterial meningitis in infants.
Main Methods:
- Retrospective analysis of pediatric meningitis cases.
- Microbiological culture and identification of pathogens.
Main Results:
- A notable increase in Hemophilus influenzae type B isolation was identified.
- This increase was most pronounced in infants aged one to two months.
- Hemophilus influenzae was present in 71% of infants aged 30-60 days.
Conclusions:
- Chloramphenicol is recommended for initial treatment of bacterial meningitis in infants over one month old.
- Early diagnosis and intensive supportive care are crucial for reducing mortality rates in pediatric meningitis.
Abstract:
Our series of children with meningitis shows an increase in the frequency of isolation of Hemophilus influenzae type B. This increase is most marked among children between one and two months of age. Since H. influenzae was found in five of the seven children between thirty and sixty days of age, we recommend the use of chloramphenicol for the initial treatment of bacterial meningitis after the first month of life. Additionally, our mortality data suggest that early diagnosis and intensive supportive therapy can contribute to a further decrease in the fatality rate of this disease.